Amyloid Precursor Protein Variant, E665D, Associated With Unique Clinical and Biomarker Phenotype

Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study

(2020) Eric M. Reiman et al.   Nature Communications

Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2

(2020) Simon Hsu et al.   NEUROBIOLOGY OF DISEASE

Investigation of white matter PiB uptake as a marker of white matter integrity

(2019) Burcu Zeydan et al.   Annals of Clinical and Translational Neurology

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease

(2019) Oskar Hansson et al.   Alzheimers Research & Therapy

Highly Elevated Cerebrospinal Fluid Total Tau Level Reflects Higher Likelihood of Non-Amnestic Subtype of Alzheimer’s Disease

(2019) Jagan A. Pillai et al.   JOURNAL OF ALZHEIMERS DISEASE

Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis

(2019) Tim Sinnecker et al.   JAMA Neurology

Biomarkers for Alzheimer's disease: current status and prospects for the future

(2018) K. Blennow et al.   JOURNAL OF INTERNAL MEDICINE

Not just amyloid: physiological functions of the amyloid precursor protein family

(2017) Ulrike C. Müller et al.   NATURE REVIEWS NEUROSCIENCE

ApoE2 and Alzheimer′s disease: time to take a closer look

(2016) Liqin Zhao et al.   Neural Regeneration Research

Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis

(2015) Celeste M. Karch et al.   BIOLOGICAL PSYCHIATRY

Amyloid PET imaging in multiple sclerosis: an 18F-florbetaben study

(2015) Jordi A. Matías-Guiu et al.   BMC Neurology

Clinical application of whole-exome sequencing across clinical indications

(2015) Kyle Retterer et al.   GENETICS IN MEDICINE

Iowa-type hereditary cerebral amyloid angiopathy in a Polish family

(2015) Piotr Iwanowski et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Cerebrospinal Fluid Biomarkers in Clinical Subtypes of Early-Onset Alzheimer's Disease

(2014) Edmond Teng et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Comparison of clinical characteristics between familial and non-familial early onset Alzheimer’s disease

(2012) Aditi Joshi et al.   JOURNAL OF NEUROLOGY

Amyloid Precursor Protein Processing and Alzheimer's Disease

(2011) Richard J. O'Brien et al.   Annual Review of Neuroscience

No evidence of APP point mutation and locus duplication in individuals with cerebral amyloid angiopathy

(2011) S. Domingues-Montanari et al.   EUROPEAN JOURNAL OF NEUROLOGY

In vivo demonstration of amyloid burden in posterior cortical atrophy: a case series with PET and CSF findings

(2011) Maïté Formaglio et al.   JOURNAL OF NEUROLOGY

CSF biomarkers in posterior cortical atrophy

(2011) J. Seguin et al.   NEUROLOGY

Correlating familial Alzheimer’s disease gene mutations with clinical phenotype

(2010) Natalie S Ryan et al.   Biomarkers in Medicine

Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy

(2010) J. Linn et al.   NEUROLOGY

Descriptive Analysis of the Boston Criteria Applied to a Dutch-Type Cerebral Amyloid Angiopathy Population

(2009) Sanneke van Rooden et al.   STROKE

The impact of apolipoprotein E on dementia in persons with Down's syndrome

(2007) A.M.W. Coppus et al.   NEUROBIOLOGY OF AGING